Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Abstract 3511: Varying Treatment outcomes of small molecule STING Agonist ADU-S100 in intratumoral and intravesical treatment regimens in syngeneic murine MB49 and in the N-methyl-N-nitrosourea (MNU) rat Model of urothelial carcinoma

Alok K. Singh, Kara Lombardo, Monali Praharaj, James Liu, Russel Becker, Kelly Harris, Max Kates, David McConkey, Andres Matoso, William R. Bishai, Trinity Jude Bivalacqua

Cancer Res (2022) 82 (12_Supplement): 3511.

https://doi.org/10.1158/1538-7445.AM2022-3511

Published: 15 June 2022

View articletitled, Abstract 3511: Varying Treatment outcomes of small molecule STING Agonist ADU-S100 in intratumoral and intravesical treatment regimens in syngeneic murine MB49 and in the N-methyl-N-nitrosourea (MNU) rat Model of urothelial carcinoma

Journal Articles

Abstract 3253: Next-gen STING-agonist like BCG confers enhanced immunogenicity and antitumor efficacy in vitro and in vivo

Alok K. Singh, Monali Praharaj, Gregory A. Joice, Takahiro Yoshida, Max Kates, David McConkey, William R. Bishai, Trinity J. Bivalacqua

Cancer Res (2019) 79 (13_Supplement): 3253.

https://doi.org/10.1158/1538-7445.AM2019-3253

Published: 01 July 2019

View articletitled, Abstract 3253: Next-gen STING-agonist like BCG confers enhanced immunogenicity and antitumor efficacy in vitro and in vivo

Journal Articles

Abstract 4589: SRC drives invasion of luminal, but not basal, bladder cancer

Bryan Wehrenberg, Andrea Ochoa, Woonyoung Choi, David McConkey

Cancer Res (2019) 79 (13_Supplement): 4589.

https://doi.org/10.1158/1538-7445.AM2019-4589

Published: 01 July 2019

View articletitled, Abstract 4589: SRC drives invasion of luminal, but not basal, bladder cancer

Journal Articles

Abstract 3093: Prognostic value of novel immune basal subtypes in muscle invasive bladder cancer

Woonyoung Choi, Debasish Sundi, I-ling Lee, Arlene Siefker-Radtke, Colin Dinney, Bogdan Czerniak, Seungchan Kim, David McConkey

Cancer Res (2019) 79 (13_Supplement): 3093.

https://doi.org/10.1158/1538-7445.AM2019-3093

Published: 01 July 2019

View articletitled, Abstract 3093: Prognostic value of novel immune basal subtypes in muscle invasive bladder cancer

Journal Articles

Abstract LB-317: Anti-invasive effects of saracatinib in preclinical models of luminal bladder cancer

Bryan Wehrenberg, David Neal, Andrea Ochoa, Woonyoung Choi, David McConkey

Cancer Res (2018) 78 (13_Supplement): LB-317.

https://doi.org/10.1158/1538-7445.AM2018-LB-317

Published: 01 July 2018

View articletitled, Abstract LB-317: Anti-invasive effects of saracatinib in preclinical models of luminal bladder cancer

Journal Articles

Abstract 1592: Bladder cancer circulating tumor cell concentration fluctuates in the absence of systemic therapy or surgery

Stephanie A. Glavaris, Heather J. Chalfin, Megan H. Fong, Eric Christenson, A. Karim Ahmed, Emily A. Caruso, John Shin, Michael Johnson, Liang Dong, Michael A. Gorin, Trinity J. Bivalacqua, Kenneth J. Pienta, Noah Hahn, David McConkey

Cancer Res (2018) 78 (13_Supplement): 1592.

https://doi.org/10.1158/1538-7445.AM2018-1592

Published: 01 July 2018

View articletitled, Abstract 1592: Bladder cancer circulating tumor cell concentration fluctuates in the absence of systemic therapy or surgery

Journal Articles

Abstract 1611: Intravesical BCG induces CD4 T Cell expansion in an immune competent model of bladder cancer

Max Kates, Thomas Nirschl, Nikolai Sopko, Noah Hahn, David McConkey, Alex Baras, Charles Drake, Trintiy Bivalacqua

Cancer Res (2017) 77 (13_Supplement): 1611.

https://doi.org/10.1158/1538-7445.AM2017-1611

Published: 01 July 2017

View articletitled, Abstract 1611: Intravesical BCG induces CD4 T Cell expansion in an immune competent model of bladder cancer

Journal Articles

Abstract 3979: Immune correlates of pathologic response in bladder cancer patients undergoing neoadjuvant chemotherapy

Philip H. Abbosh, David Liu, Woonyoung Choi, Wafik S. El-Deiry, Jonathan E. Rosenberg, David McConkey, Elizabeth R. Plimack, Eliezer M. Van Allen

Cancer Res (2017) 77 (13_Supplement): 3979.

https://doi.org/10.1158/1538-7445.AM2017-3979

Published: 01 July 2017

View articletitled, Abstract 3979: Immune correlates of pathologic response in bladder cancer patients undergoing neoadjuvant chemotherapy

Journal Articles

Abstract 5172: Forerunner genes contribute to bladder carcinogenesis by altering the basal to luminal urothelial transition program

Sangkyou Lee, Jolanta Bondaruk, Sooyoung Lee, June G. Lee, Tadeusz Majewski, Woonyoung Choi, Charles Guo, Colin Dinney, Li Zhang, Keith Baggerly, Richard Behringer, David McConkey, Bogdan Czerniak

Cancer Res (2016) 76 (14_Supplement): 5172.

https://doi.org/10.1158/1538-7445.AM2016-5172

Published: 15 July 2016

View articletitled, Abstract 5172: Forerunner genes contribute to bladder carcinogenesis by altering the basal to luminal urothelial transition program

Journal Articles

Abstract 4809: Validation of molecular subtypes of urothelial carcinoma of bladder in multi-institutional and public cohorts

Vipulkumar Dadhania, Charles G. Guo, Tadeusz Majewski, Li Zhang, Jolanta Bondaruk, Shizhen Zhang, Woonyoung Choi, David McConkey, Colin Dinney, Keith Baggerly, Bogdan A. Czerniak

Cancer Res (2015) 75 (15_Supplement): 4809.

https://doi.org/10.1158/1538-7445.AM2015-4809

Published: 01 August 2015

View articletitled, Abstract 4809: Validation of molecular subtypes of urothelial carcinoma of bladder in multi-institutional and public cohorts

Journal Articles

Abstract 5256: Mechanism of field cancerization

Cancer Res (2014) 74 (19_Supplement): 5256.

https://doi.org/10.1158/1538-7445.AM2014-5256

Published: 01 October 2014

View articletitled, Abstract 5256: Mechanism of field cancerization

Journal Articles

Abstract 307: Germline ablation of candidate forerunner gene, P2RY5, in a mouse model.

Bogdan A. Czerniak, Sangkyou Lee, Ying Wang, Jolanta Bondaruk, Taddeusz Majewski, Woongyoung Choi, David McConkey, Richard R. Behringer

Cancer Res (2013) 73 (8_Supplement): 307.

https://doi.org/10.1158/1538-7445.AM2013-307

Published: 15 April 2013

View articletitled, Abstract 307: Germline ablation of candidate forerunner gene, P2RY5, in a mouse model.

Journal Articles

Abstract 4098: COX-2 expression in human pancreatic cancer cells is associated with an epithelial phenotype

Gil S. Freitas, Aditi das, Matthew White, David McConkey

Cancer Res (2012) 72 (8_Supplement): 4098.

https://doi.org/10.1158/1538-7445.AM2012-4098

Published: 15 April 2012

View articletitled, Abstract 4098: COX-2 expression in human pancreatic cancer cells is associated with an epithelial phenotype

Journal Articles

Abstract 4837: Integrated genome sequence, epigenome, and transcriptome map of bladder cancer development

Bogdan Czerniak, Taddeusz Majewski, Woonbok Chung, Hu Limei, David Cogdell, Jolanta Bondaruk, Shizhen Zhang, Sangkyou Lee, Sooyong Lee, Li Shen, Caimiao Wei, Suk Young Yoo, Woonyoung Choi, David McConkey, John Weinstein, Keith Baggerly, Jean-Pierre Issa, Wei Zhang, Steve E. Scherer

Cancer Res (2011) 71 (8_Supplement): 4837.

https://doi.org/10.1158/1538-7445.AM2011-4837

Published: 15 April 2011

View articletitled, Abstract 4837: Integrated genome sequence, epigenome, and transcriptome map of bladder cancer development

Journal Articles

Autophagic Survival in Resistance to Histone Deacetylase Inhibitors: Novel Strategies to Treat Malignant Peripheral Nerve Sheath Tumors

Gonzalo Lopez, Keila Torres, Juehui Liu, Belinda Hernandez, Eric Young, Roman Belousov, Svetlana Bolshakov, Alexander J. Lazar, John M. Slopis, Ian E. McCutcheon, David McConkey, Dina Lev

Cancer Res (2011) 71 (1): 185–196.

https://doi.org/10.1158/0008-5472.CAN-10-2799

Published: 02 January 2011

View articletitled, Autophagic Survival in Resistance to Histone Deacetylase Inhibitors: Novel Strategies to Treat Malignant Peripheral Nerve Sheath Tumors

Includes: Supplementary data

Journal Articles

Abstract 894: Genetic variations in the angiogenesis pathway modulate clinical outcomes of bladder cancer

Meng Chen, Seth Lerner, David McConkey, Jian Gu, Ashish Kamat, H. Barton Grossman, Colin P. Dinney, Xifeng Wu

Cancer Res (2010) 70 (8_Supplement): 894.

https://doi.org/10.1158/1538-7445.AM10-894

Published: 15 April 2010

View articletitled, Abstract 894: Genetic variations in the angiogenesis pathway modulate clinical outcomes of bladder cancer

Journal Articles

Abstract #2425: Gene expression profiling implicates EMT in global drug resistance in pancreatic cancer

Woonyoung choi, Thiru Arumugam, Keith Fournier, Vijaya Ramachandran, James Abbruzzese, Gary Gallick, Craig Logsdon, David McConkey

Cancer Res (2009) 69 (9_Supplement): 2425.

Published: 01 May 2009

View articletitled, Abstract #2425: Gene expression profiling implicates EMT in global drug resistance in pancreatic cancer

Journal Articles

Abstract #3510: Restoration of E-cadherin by differential regulation is responsible for sensitizing a subset of urothelial carcinoma cells

Aditi Das, Robert Svatek, Anne Kwan, Woonyoung Choi, Jay Shah, Colin Dinney, David Mcconkey

Cancer Res (2009) 69 (9_Supplement): 3510.

Published: 01 May 2009

View articletitled, Abstract #3510: Restoration of E-cadherin by differential regulation is responsible for sensitizing a subset of urothelial carcinoma cells

Journal Articles

Abstract #1876: Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells

Keyi Zhu, Kenneth Dunner, David McConkey

Cancer Res (2009) 69 (9_Supplement): 1876.

Published: 01 May 2009

View articletitled, Abstract #1876: Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells

Journal Articles

ErbB4 regulates epidermal growth factor receptor tyrosine kinase inhibition in urothelial carcinoma

Teruo Inamoto, Peter Black, Mark Fisher, Paul Hegarty, Ameeta Arora, Menashe Bar-Eli, Liana Adam, David McConkey, Colin Dinney

Cancer Res (2008) 68 (9_Supplement): 668.

Published: 01 May 2008

View articletitled, ErbB4 regulates epidermal growth factor receptor tyrosine kinase inhibition in urothelial carcinoma

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 3511: Varying Treatment outcomes of small molecule STING Agonist ADU-S100 in intratumoral and intravesical treatment regimens in syngeneic murine MB49 and in the N-methyl-N-nitrosourea (MNU) rat Model of urothelial carcinoma

Abstract 3253: Next-gen STING-agonist like BCG confers enhanced immunogenicity and antitumor efficacy in vitro and in vivo

Abstract 4589: SRC drives invasion of luminal, but not basal, bladder cancer

Abstract 3093: Prognostic value of novel immune basal subtypes in muscle invasive bladder cancer

Abstract LB-317: Anti-invasive effects of saracatinib in preclinical models of luminal bladder cancer

Abstract 1592: Bladder cancer circulating tumor cell concentration fluctuates in the absence of systemic therapy or surgery

Abstract 1611: Intravesical BCG induces CD4 T Cell expansion in an immune competent model of bladder cancer

Abstract 3979: Immune correlates of pathologic response in bladder cancer patients undergoing neoadjuvant chemotherapy

Abstract 5172: Forerunner genes contribute to bladder carcinogenesis by altering the basal to luminal urothelial transition program

Abstract 4809: Validation of molecular subtypes of urothelial carcinoma of bladder in multi-institutional and public cohorts

Abstract 5256: Mechanism of field cancerization

Abstract 307: Germline ablation of candidate forerunner gene, P2RY5, in a mouse model.

Abstract 4098: COX-2 expression in human pancreatic cancer cells is associated with an epithelial phenotype

Abstract 4837: Integrated genome sequence, epigenome, and transcriptome map of bladder cancer development

Autophagic Survival in Resistance to Histone Deacetylase Inhibitors: Novel Strategies to Treat Malignant Peripheral Nerve Sheath Tumors

Abstract 894: Genetic variations in the angiogenesis pathway modulate clinical outcomes of bladder cancer

Abstract #2425: Gene expression profiling implicates EMT in global drug resistance in pancreatic cancer

Abstract #3510: Restoration of E-cadherin by differential regulation is responsible for sensitizing a subset of urothelial carcinoma cells

Abstract #1876: Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells

ErbB4 regulates epidermal growth factor receptor tyrosine kinase inhibition in urothelial carcinoma

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only